LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
CAMBER PHARMACE
Indication
Marginal zone lymphoma
Marginal zone lymphoma is a heterogeneous group of indolent B-cell non-Hodgkin lymphomas originating from memory B lymphocytes residing in the marginal zones of secondary lymphoid follicles. Read more about Marginal zone lymphoma
26 drugs 22 manufacturers
Drugs that treat it
Common Marginal zone lymphoma therapies.
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
ALVOGEN INC
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
DR.REDDY'S LAB
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
APOTEX CORP
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
SUN PHARMACEUTI
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
AUROBINDO PHARM
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
CIPLA USA, INC.
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
BIOCON PHARMA I
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS·MULTIPLE MYELOMA·+6
ZYDUS PHARMACEU
Filter & compare in the drug finder →Opens the drug finder with Marginal zone lymphoma preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMarginal zone lymphoma is a heterogeneous group of indolent B-cell non-Hodgkin lymphomas originating from memory B lymphocytes residing in the marginal zones of secondary lymphoid follicles.
Affecting primarily older adults, it involves the lymphatic and reticuloendothelial systems and is classified into three distinct subtypes: extranodal mucosa-associated lymphoid tissue (MALT) lymphoma, splenic marginal zone lymphoma, and nodal marginal zone lymphoma.
Pathophysiologically, the malignancy frequently arises from persistent immune stimulation driven by chronic infections—such as *Helicobacter pylori*—or autoimmune disorders, leading to clonal B-cell proliferation.
Clinical manifestations vary by subtype and anatomical involvement, typically featuring localized or disseminated lymphadenopathy, splenomegaly, cytopenias, or organ-specific symptoms in extranodal sites such as the gastrointestinal tract.
- nih.gov
Marginal zone lymphoma is a heterogeneous group of indolent B-cell non-Hodgkin lymphomas originating from memory B lymphocytes residing in the marginal zones of secondary lymphoid follicles Affecting primarily older adults, it involves the lymphatic and reticuloendothelial systems and is classified into three distinct subtypes: extranodal mucosa-associated lymphoid tissue (MALT) lymphoma, splenic marginal zone lymphoma, and nodal marginal zone lymphoma Clinical manifestations vary by subtype and...
- mayoclinic.org
Marginal zone lymphoma is a heterogeneous group of indolent B-cell non-Hodgkin lymphomas originating from memory B lymphocytes residing in the marginal zones of secondary lymphoid follicles Affecting primarily older adults, it involves the lymphatic and reticuloendothelial systems and is classified into three distinct subtypes: extranodal mucosa-associated lymphoid tissue (MALT) lymphoma, splenic marginal zone lymphoma, and nodal marginal zone lymphoma Pathophysiologically, the malignancy freque...
- nih.gov
Marginal zone lymphoma is a heterogeneous group of indolent B-cell non-Hodgkin lymphomas originating from memory B lymphocytes residing in the marginal zones of secondary lymphoid follicles
- mdanderson.org
Affecting primarily older adults, it involves the lymphatic and reticuloendothelial systems and is classified into three distinct subtypes: extranodal mucosa-associated lymphoid tissue (MALT) lymphoma, splenic marginal zone lymphoma, and nodal marginal zone lymphoma Pathophysiologically, the malignancy frequently arises from persistent immune stimulation driven by chronic infections—such as *Helicobacter pylori*—or autoimmune disorders, leading to clonal B-cell proliferation Clinical manifestati...
- nih.gov
Pathophysiologically, the malignancy frequently arises from persistent immune stimulation driven by chronic infections—such as *Helicobacter pylori*—or autoimmune disorders, leading to clonal B-cell proliferation
Personalize your experience
Follow Marginal zone lymphoma and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.